Oct
2026
Fiera Milano, Italy
Visit us
stand 2H104, API
Elementis Pharma GmbH
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:Germany
-
On CPHI since:2015
-
Employees:50 - 99
Company types
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 2H104, API
Products Featured at CPHI Milan 2026
-
Product Almagate Al2Mg6(OH)14(CO3)2 · x H2O
Elementis Pharma GmbH offers a wide range of products which includes Almagate Al2Mg6(OH)14(CO3)2 · x H2O. It belongs to antacid compounds category. Almagate is a crystalline compound similar to hydrotalcite. It reacts very rapidly with gastric acid even in the presence of pepsin and proteins. Contact us fo... -
Product Almagate Powder C 310
Elementis Pharma GmbH offers a wide range of products which includes Almagate Powder C 310. It belongs to antacid compounds category. C310 is a spray dried powder with similar properties to hydrotalcite powder. It is suitable for the production of fast acting tablets. Contact us for more information. -
Product Almagate Suspension C 610
Elementis Pharma GmbH offers a wide range of products which includes Almagate Suspension C 610. It belongs to antacid compounds category. C610 has an almagate content of ca. 16%. It is ideal for use in liquid antacid formulations. Contact us for more information. -
Product Almasilate Powder C 212 Almasilate Suspension C 612
Elementis Pharma GmbH offers a wide range of products which includes Almasilate Powder C 212 Almasilate Suspension C 612. It belongs to antacid compounds category. Almasilate types C 212 and C 612 are standard grades of aluminium magnesium hydroxysilicate. They have a rapid reaction velocity and high acid ... -
Product Alugel® A 211
Elementis Pharma GmbH offers a wide range of products which includes Alugel® A 211. It belongs to antacid compounds category. Alugel® A 211 is the most widely used active for tablet, granulate or powder manufacture. Its high reaction capacity with hydrochloric acid ensures rapid onset and prolonged action ...
